Telehealth Diabetes Prevention Program for Adults With Prediabetes in an Academic Medical Center Setting: Protocol for a Hybrid Type III Trial.
Centers for Disease Control and Prevention
Medicare
behavioral science
cost
cost-benefit analysis
costs
design
diabetes
diabetic
distant learning
economic
engagement
implementation
implementation science
prediabetic state
prevention
preventive medicine
research evaluation
telehealth
telemedicine
use
Journal
JMIR research protocols
ISSN: 1929-0748
Titre abrégé: JMIR Res Protoc
Pays: Canada
ID NLM: 101599504
Informations de publication
Date de publication:
13 Nov 2023
13 Nov 2023
Historique:
received:
06
07
2023
accepted:
21
09
2023
revised:
12
09
2023
medline:
13
11
2023
pubmed:
13
11
2023
entrez:
13
11
2023
Statut:
epublish
Résumé
Diabetes is a costly epidemic in the United States associated with both health and economic consequences. These consequences can be mitigated by participation in structured lifestyle change programs such as the National Diabetes Prevention Program (DPP) led by the Centers for Disease Control and Prevention. Mississippi consistently has among the highest rates of diabetes and prediabetes nationally. Implementing the National DPP through large health care systems can increase reach and accessibility for populations at the highest risk for diabetes. Translational research on the National DPP in Mississippi has not been studied. This study aims to evaluate the implementation and impact of the National DPP delivered using telehealth modalities at the University of Mississippi Medical Center in Jackson, Mississippi. An effectiveness-implementation hybrid type III research design is proposed. The study design is guided by the Reach, Effectiveness, Adoption, Implementation, and Maintenance framework and the Practical, Robust Implementation and Sustainability Model. Participants are being recruited via provider referral, and the DPP is being delivered by trained lifestyle coaches. Study participants include adult (≥18 years) patients eligible for the DPP with at least 1 encounter at 1 of 3 ambulatory clinic specialties (lifestyle medicine, family medicine, and internal medicine) between January 2019 and December 2023. The National DPP eligibility criteria include a BMI ≥25 kg/m At baseline, of the 26,151 patients across 3 ambulatory clinic specialties, 1010 (3.9%) had prediabetes and were eligible for the National DPP. Of the 1010 patients, more than half (n=562, 55.6%) were aged 65 years or older, 79.5% (n=803) were Medicare beneficiaries, 65.9% (n=666) were female, and 70.8% (n=715) were obese. This is the first translational study of the National DPP in Mississippi. The findings will inform implementation strategies impacting the uptake and sustainability of the National DPP delivered in an academic medical setting using distance learning and telehealth modalities. ClinicalTrials.gov NCT04822480; https://clinicaltrials.gov/study/NCT03622580. DERR1-10.2196/50183.
Sections du résumé
BACKGROUND
BACKGROUND
Diabetes is a costly epidemic in the United States associated with both health and economic consequences. These consequences can be mitigated by participation in structured lifestyle change programs such as the National Diabetes Prevention Program (DPP) led by the Centers for Disease Control and Prevention. Mississippi consistently has among the highest rates of diabetes and prediabetes nationally. Implementing the National DPP through large health care systems can increase reach and accessibility for populations at the highest risk for diabetes. Translational research on the National DPP in Mississippi has not been studied.
OBJECTIVE
OBJECTIVE
This study aims to evaluate the implementation and impact of the National DPP delivered using telehealth modalities at the University of Mississippi Medical Center in Jackson, Mississippi.
METHODS
METHODS
An effectiveness-implementation hybrid type III research design is proposed. The study design is guided by the Reach, Effectiveness, Adoption, Implementation, and Maintenance framework and the Practical, Robust Implementation and Sustainability Model. Participants are being recruited via provider referral, and the DPP is being delivered by trained lifestyle coaches. Study participants include adult (≥18 years) patients eligible for the DPP with at least 1 encounter at 1 of 3 ambulatory clinic specialties (lifestyle medicine, family medicine, and internal medicine) between January 2019 and December 2023. The National DPP eligibility criteria include a BMI ≥25 kg/m
RESULTS
RESULTS
At baseline, of the 26,151 patients across 3 ambulatory clinic specialties, 1010 (3.9%) had prediabetes and were eligible for the National DPP. Of the 1010 patients, more than half (n=562, 55.6%) were aged 65 years or older, 79.5% (n=803) were Medicare beneficiaries, 65.9% (n=666) were female, and 70.8% (n=715) were obese.
CONCLUSIONS
CONCLUSIONS
This is the first translational study of the National DPP in Mississippi. The findings will inform implementation strategies impacting the uptake and sustainability of the National DPP delivered in an academic medical setting using distance learning and telehealth modalities.
TRIAL REGISTRATION
BACKGROUND
ClinicalTrials.gov NCT04822480; https://clinicaltrials.gov/study/NCT03622580.
INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID)
UNASSIGNED
DERR1-10.2196/50183.
Identifiants
pubmed: 37955955
pii: v12i1e50183
doi: 10.2196/50183
pmc: PMC10682930
doi:
Banques de données
ClinicalTrials.gov
['NCT03622580', 'NCT04822480']
Types de publication
Journal Article
Langues
eng
Pagination
e50183Informations de copyright
©Abigail Gamble, Tamkeen Khan, Alejandro Hughes, Yan Guo, Siga Vasaitis, Josie Bidwell, Brian Christman. Originally published in JMIR Research Protocols (https://www.researchprotocols.org), 13.11.2023.
Références
Implement Sci. 2019 Aug 14;14(1):81
pubmed: 31412894
Front Public Health. 2019 Aug 14;7:209
pubmed: 31475126
Front Public Health. 2019 Jun 18;7:158
pubmed: 31275915
Diabetes Care. 2020 Sep;43(9):2042-2049
pubmed: 32616617
Am J Manag Care. 2020 Jun 1;26(6):e198-e201
pubmed: 32549070
Prev Chronic Dis. 2017 Dec 07;14:E130
pubmed: 29215975
Implement Sci. 2009 Aug 07;4:50
pubmed: 19664226
Diabetes Care. 2017 Oct;40(10):1331-1341
pubmed: 28500215
Prev Chronic Dis. 2018 Sep 06;15:E109
pubmed: 30191810
Am J Health Behav. 2005 Jan-Feb;29(1):57-69
pubmed: 15604050
Lancet. 2012 Jun 16;379(9833):2279-90
pubmed: 22683128
Diabetes Care. 2018 May;41(5):917-928
pubmed: 29567642
AIDS Educ Prev. 2006 Aug;18(4 Suppl A):59-73
pubmed: 16987089
Transl Behav Med. 2020 Dec 31;10(6):1554-1558
pubmed: 31228199
BMJ Open. 2018 Mar 1;8(3):e017111
pubmed: 29500199
Med Care. 2012 Mar;50(3):217-26
pubmed: 22310560
Med Care. 2018 Nov;56(11):908-911
pubmed: 30312286
Implement Sci. 2017 Jul 26;12(1):94
pubmed: 28747191
Diabetes Care. 2012 Apr;35(4):723-30
pubmed: 22442395
BMJ. 2017 Mar 6;356:i6795
pubmed: 28264797
J Gen Intern Med. 2006 Feb;21 Suppl 2:S1-8
pubmed: 16637954
Curr Diab Rep. 2020 Feb 20;20(3):9
pubmed: 32080770
Am J Public Health. 1999 Sep;89(9):1322-7
pubmed: 10474547
N Engl J Med. 2002 Feb 7;346(6):393-403
pubmed: 11832527
J Diabetes Res. 2017;2017:2615681
pubmed: 28890899
Implement Sci. 2015 Feb 12;10:21
pubmed: 25889199
Popul Health Manag. 2017 Oct;20(5):389-396
pubmed: 28192030
Am J Prev Med. 2013 Apr;44(4 Suppl 4):S346-51
pubmed: 23498297
Popul Health Manag. 2021 Feb;24(1):46-51
pubmed: 32013762
Am J Prev Med. 2011 Apr;40(4):434-9
pubmed: 21406277